BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 17656176)

  • 21. Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: a pilot study(1).
    Monteiro I; Bahamondes L; Diaz J; Perrotti M; Petta C
    Contraception; 2002 May; 65(5):325-8. PubMed ID: 12057782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
    Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower urinary tract symptoms: a 10-year follow-up study of a randomised trial.
    Heliövaara-Peippo S; Halmesmäki K; Hurskainen R; Teperi J; Grenman S; Kivelä A; Tomas E; Tuppurainen M; Paavonen J
    BJOG; 2010 Apr; 117(5):602-9. PubMed ID: 20156209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower abdominal pain and back pain among women treated for menorrhagia: a five-year randomized controlled trial.
    Heliövaara-Peippo S; Halmesmäki K; Hurskainen R; Teperi J; Grenman S; Kivelä A; Kujansuu E; Tuppurainen M; Vuorma S; Yliskoski M; Paavonen J
    Acta Obstet Gynecol Scand; 2009; 88(12):1389-96. PubMed ID: 19878089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.
    Pakarinen P; Lähteenmäki P; Rutanen EM
    Acta Obstet Gynecol Scand; 1999 May; 78(5):423-8. PubMed ID: 10326889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term use of the levonorgestrel-releasing intrauterine system.
    Inki P
    Contraception; 2007 Jun; 75(6 Suppl):S161-6. PubMed ID: 17531611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The levonorgestrel intrauterine system (Mirena) for treatment of idiopathic menorrhagia. Assessment of quality of life and satisfaction.
    Lete I; Obispo C; Izaguirre F; Orte T; Rivero B; Cornellana MJ; Bermejo I;
    Eur J Contracept Reprod Health Care; 2008 Sep; 13(3):231-7. PubMed ID: 18609346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
    Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on sexual functioning among women with menorrhagia: a 5-year randomised controlled trial.
    Halmesmäki K; Hurskainen R; Teperi J; Grenman S; Kivelä A; Kujansuu E; Tuppurainen M; Yliskoski M; Vuorma S; Paavonen J
    BJOG; 2007 May; 114(5):563-8. PubMed ID: 17439564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: effects on ovarian function and uterus.
    Tasci Y; Caglar GS; Kayikcioglu F; Cengiz H; Yagci B; Gunes M
    Arch Gynecol Obstet; 2009 Jul; 280(1):39-42. PubMed ID: 19066923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subject and clinician experience with the levonorgestrel-releasing intrauterine system.
    Jensen JT; Nelson AL; Costales AC
    Contraception; 2008 Jan; 77(1):22-9. PubMed ID: 18082662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding.
    Crosignani PG; Vercellini P; Mosconi P; Oldani S; Cortesi I; De Giorgi O
    Obstet Gynecol; 1997 Aug; 90(2):257-63. PubMed ID: 9241305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby AE; Cooke I; Rees M
    Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of the Levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users.
    Gorgen H; Api M; Akça A; Cetin A
    Arch Gynecol Obstet; 2009 Jun; 279(6):835-40. PubMed ID: 19018547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized prospective trial comparing the levonorgestrel-releasing intrauterine system with thermal balloon ablation for the treatment of heavy menstrual bleeding.
    de Souza SS; Camargos AF; de Rezende CP; Pereira FA; Araújo CA; Silva Filho AL
    Contraception; 2010 Mar; 81(3):226-31. PubMed ID: 20159179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.
    Wildemeersch D; Janssens D; Vrijens M; Weyers S
    Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of the levonorgestrel-releasing intrauterine system in perimenopausal women with menorrhagia or dysmenorrhea.
    Yoo HJ; Lee MA; Ko YB; Yang JB; Kang BH; Lee KH
    Arch Gynecol Obstet; 2012 Jan; 285(1):161-6. PubMed ID: 21671063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The levonorgestrel intrauterine system is an effective treatment in women with abnormal uterine bleeding and anticoagulant therapy.
    Vilos GA; Tureanu V; Garcia M; Abu-Rafea B
    J Minim Invasive Gynecol; 2009; 16(4):480-4. PubMed ID: 19573825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.